Immage Biotherapeutics Corp. (IMMG)
Immage Biotherapeutics Corp. operates in the Financial - Conglomerates industry of the Financial Services sector, headquartered in Bethesda, MD, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $15,174. On trailing twelve-month figures it carries a trailing P/E of -0.07, a net margin of 0.0%. Its beta of 32.51 implies it has historically moved more than the broad market.
Presently, Immage Biotherapeutics Corp. lacks substantial business operations. Historically, its endeavors centered on the creation of cutting-edge immunotherapy biologics designed to combat diverse cancer types across the United States. Established in 2012, the entity was initially known as Epicure Charcoal, Inc., rebranding to Immage Biotherapeutics Corp. in June 2015. Its corporate headquarters are situated in Bethesda, Maryland, and it operates as a subsidiary of Coventry International Limited.
Immage Biotherapeutics Corp. is most often compared with the following Financial Services names: